Do colorectal cancer resections improve diabetes in long-term survivors? A case-control study

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, v.28, n.3, p.1019-1026, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
A clinical study was designed that aimed to analyze whether resection of the large bowel in cancer patients might benefit diabetes mellitus. This prospective case-control study included retrospective information. Patients (n = 247) included diabetic and euglycemic groups with colorectal cancer operations (n = 60), cancer gastrectomy (n = 72), exclusive chemoradiotherapy for rectal cancer (n = 46), and noncancer clinical controls (n = 69). Follow-up periods were, respectively, 79.2 +/- A 27.4, 86.8 +/- A 25.1, 70.0 +/- A 26.3, and 85.1 +/- A 18.2 months (NS). Diabetes groups included patients with prediabetes. Diabetes remission, defined as conversion from diabetes to prediabetes or from this condition to normal, was documented in, respectively, 32.4 % (11 of 34), 41.2 % (14 of 34), 7.1 % (1 of 14), and 7.7 % (3 of 39) in the four cohorts (P = 0.004). Within the same period, progression of euglycemic participants to diabetes occurred in 30.8 % (8 of 26), 63.2 % (24 of 38), 25.0 (8 of 32), and 20.0 % (6 of 30) (P = 0.028). Diabetes amelioration was associated with weight loss in gastrectomy patients but not in the other groups. Dietary intake, estimated in the two surgical populations, did not predict outcome. Diabetes amelioration after colorectal interventions was demonstrated, but progression of euglycemic patients toward prediabetes was not changed in comparison with nonsurgical controls. It is speculated that reshaping of the bowel microbiome or hormone changes after colorectal interventions underlay the improvement in diabetes. Body weight fluctuations could not be incriminated in this investigation.
Palavras-chave
Beta cell function, Body mass index, Colorectal cancer, Colorectal resection, Diabetes mellitus, Dietary intake, Glucose homeostasis, Gut microbiome, New-onset diabetes
Referências
  1. American Diabetes Association, 2010, DIABETES CARE S1, V33, pS62, DOI 10.2337/DC10-S062
  2. Adrian TE, 2012, DIABETOLOGIA, V55, P2343, DOI 10.1007/s00125-012-2593-2
  3. Bech-Nielsen GV, 2012, RES VET SCI, V92, P501, DOI 10.1016/j.rvsc.2011.04.005
  4. van de Poll-Franse LV, 2012, DIABETOLOGIA, V55, P2163, DOI 10.1007/s00125-012-2555-8
  5. Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863
  6. Herman WH, 2013, AM J MANAG CARE, V19, P194
  7. Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303
  8. Khan NF, 2011, BRIT J CANCER, V105, pS29, DOI 10.1038/bjc.2011.420
  9. Weaver KE, 2013, J CANCER SURVIV, V7, P253, DOI 10.1007/s11764-013-0267-9
  10. Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x
  11. Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
  12. Ashrafian H, 2011, OBES REV, V12, pe257, DOI 10.1111/j.1467-789X.2010.00802.x
  13. Polednak AP, 2006, CANCER DETECT PREV, V30, P466, DOI 10.1016/j.cdp.2006.07.003
  14. Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110
  15. Yeh HC, 2012, DIABETES CARE, V35, P113, DOI 10.2337/dc11-0255
  16. Yamaguchi CM, 2012, SURG ENDOSC, V26, P2843, DOI 10.1007/s00464-012-2256-x
  17. Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4
  18. Hayashi SY, 2013, SURG ENDOSC, V27, P2829, DOI 10.1007/s00464-013-2829-3
  19. Underwood J. Michael, 2012, Morbidity and Mortality Weekly Report, V61, P1
  20. Wu T, 2013, DIABETES OBES METAB, V15, P474, DOI 10.1111/dom.12043
  21. Babu M, 2005, REGUL PEPTIDES, V131, P29, DOI 10.1016/j.regpep.2005.06.004
  22. Cani Patrice D, 2012, Gut Microbes, V3, P279, DOI 10.4161/gmic.19625
  23. Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212
  24. Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076
  25. Graessler J, 2012, PHARMACOGENOMICS, DOI [10.1038/tpj.2012.43, DOI 10.1038/TPJ.2012.43]
  26. Gravitz L, 2012, NATURE, V485, pS12
  27. Stratis C, 2006, OBES SURG, V16, P752, DOI 10.1381/096089206777346772